HRTX Reports $34.7M Q1 Revenue, +32% Acute Care Growth, Reaffirms $173-183M FY Guidance
Heron Therapeutics, Inc. · PHARMACEUTICAL PREPARATIONS · Now $0.83
-12% in 7d after detection
Post-detection moves
1h
—
1d
+0.9%
3d
-4.5%
7d
-12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS